Results
|
90361.
|
|
|
90362.
|
|
|
90363.
|
|
|
90364.
|
|
|
90365.
|
|
|
90366.
|
|
|
90367.
|
|
|
90368.
|
|
|
90369.
|
|
|
90370.
|
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism. [electronic resource] by
- Siccardi, Marco
- D'Avolio, Antonio
- Nozza, Silvia
- Simiele, Marco
- Baietto, Lorena
- Stefani, Francesca Romana
- Moss, Darren
- Kwan, Wai-San
- Castagna, Antonella
- Lazzarin, Adriano
- Calcagno, Andrea
- Bonora, Stefano
- Back, David
- Di Perri, Giovanni
- Owen, Andrew
Producer: 20110714
In:
Pharmacogenetics and genomics vol. 20
Availability: No items available.
|
|
90371.
|
|
|
90372.
|
|
|
90373.
|
|
|
90374.
|
|
|
90375.
|
Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugs. [electronic resource] by
- Walsky, Robert L
- Obach, R Scott
- Hyland, Ruth
- Kang, Ping
- Zhou, Sue
- West, Michael
- Geoghegan, Kieran F
- Helal, Christopher J
- Walker, Gregory S
- Goosen, Theunis C
- Zientek, Michael A
Producer: 20130117
In:
Drug metabolism and disposition: the biological fate of chemicals vol. 40
Availability: No items available.
|
|
90376.
|
|
|
90377.
|
|
|
90378.
|
|
|
90379.
|
|
|
90380.
|
|